Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,675.50
Bid: 1,675.50
Ask: 1,676.00
Change: 22.50 (1.36%)
Spread: 0.50 (0.03%)
Open: 1,650.00
High: 1,677.00
Low: 1,646.00
Prev. Close: 1,653.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reuters Health News Summary

Thu, 29th Mar 2018 13:56

Following is a summary of current health news briefs.

Less heart disease, stroke in immigrants than in U.S.-born

People living in the U.S. but born elsewhere may have lowerrisk for heart disease and stroke than their native-bornneighbors, suggests a new study. Foreign-born residents had arange of risks, however. Women from Europe and men from Africaor South America had the lowest stroke rates compared toU.S.-born peers. Heart disease rates were lowest among men andwomen from Asia, the Caribbean, Central America and Mexico andhighest among men from the Indian Subcontinent and Europe.

First women's yoga training center opens doors in Gaza

A small group of Palestinian women in Gaza are stretchingtheir limbs with yoga to help them teach others to cope with thestresses and traumas of living in the embattled territory. TheGaza Strip, which is dominated by the Islamist Hamas faction,has experienced three wars with neighboring Israel in the past11 years.

Happiness 101: Psychology course strikes chord with Yalestudents

The search for life's sweetest but most elusive treasure -happiness - brings nearly 1,200 Yale University undergraduatestwice a week into an enormous hall on the Connecticut school'scampus for its most popular class ever. "Psychology and the GoodLife" is such a hit that one in four undergraduate students atthe Ivy League university is enrolled in the spring semestercourse, said Laurie Santos, the psychology professor who teachesthe class. It is the largest class enrollment size in thehistory of Yale, founded in 1701.

Teva wins reversal of U.S. jury's $235 million GSK drugpatent verdict

A federal judge on Wednesday overturned a U.S. jury'sverdict that required Teva Pharmaceutical Industries Ltdto pay GlaxoSmithKline Plc more than $235million for infringing a patent covering its blood pressure drugCoreg. U.S. District Judge Leonard Stark in Wilmington, Delawareruled that the evidence did not support the jury's finding inJune that Teva sales of a generic version of the drug causeddoctors to infringe GSK's patent.

Childhood cancer survivors may develop heart problems sooner

Adult survivors of childhood cancer have a greater risk ofheart disease and develop risk factors like high blood pressureand elevated cholesterol earlier in life compared to the generalpopulation, a German study suggests. Researchers studied 951adults, ages 23 to 48, who had been diagnosed with cancer whenthey were less than 15 years old. The study team looked at labtests for risk factors for heart disease, and also forconditions like heart failure, stroke and heart attacks. Alongwith the cancer survivors, they studied more than 15,000similar people who didn’t have malignancies as children.

Ireland sets abortion referendum date for May 25

Ireland will hold a referendum on May 25 on whether or notto liberalize its abortion law, the first opportunity in 35years to overhaul one of the world's strictest regimes that haslong divided the once deeply Catholic nation. A complete ban onabortion was only lifted five years ago for cases where themother's life was in danger. That move fueled calls to givevoters under the age of 50 their first say on more comprehensivereform.

Colon cancer screening rates vary widely across U.S.

The proportion of U.S. adults who get recommended coloncancer screenings has never been as high as doctors would like,but a new study suggests that it’s much lower than expected insome pockets of the country. To catch colon cancer early, whenit’s easier to treat and less lethal, physicians typicallyrecommend that adults aged 50 to 75 get screened every 10 yearswith a colonoscopy or annually with fecal tests. Nationwide,only about 67 percent of adults in this age range were currentwith screening, the study found.

FDA working on a 'dozen' policies to boost copycat biotechdrugs

The U.S. Food & Drug Administration is working on around adozen actions to boost use of cheaper versions of expensivebiotech medicines, the head of the agency Scott Gottlieb said onWednesday. The United States has lagged behind Europe in use ofso-called biosimilars, to the frustration of FDA policymakerswho are starting to approve such products but who are seeingother impediments to getting them to consumers.

Listeria class action filed against South Africa's TigerBrands

A class action lawsuit was filed on Thursday against SouthAfrica's Tiger Brands, after one of its food factorieswas linked to a listeria outbreak that has killed 180 peoplesince early 2017, the lawyer running the case said. RichardSpoor, a human rights advocate who previously masterminded amassive class action on behalf of gold miners with silicosis,filed the lawsuit on behalf of families affected by the listeriaoutbreak. The case against Tiger Brands was clear, Spoor said.

Pregnant? Warm weather exercise and hot baths might be okay

Pregnant women who exercise outside on warm days or spend alittle time in a hot bath or sauna may not necessarily raisetheir body temperature enough to cause problems, a researchreview suggests. While most women without health problems cansafely exercise during pregnancy, doctors discourage workouts inhot weather because it can lead to heat stress and dehydration.Physicians also advise women to avoid saunas and hot tubsbecause these activities can raise the body temperature andincrease the risk of birth defects.

More News
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.